These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Pharmacologic approaches to cognitive deficits in Alzheimer's disease. Peskind ER J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483 [TBL] [Abstract][Full Text] [Related]
28. [Plurality of patterns of cognitive impairment in normal aging and in dementia]. Joanette Y; Belleville S; Gely-Nargeot M; Ska B; Valdois S Rev Neurol (Paris); 2000 Sep; 156(8-9):759-66. PubMed ID: 10992120 [TBL] [Abstract][Full Text] [Related]
29. Psychopharmacological strategies in the search for cognition enhancers. Sanger DJ; Joly D Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():70-4. PubMed ID: 2186417 [TBL] [Abstract][Full Text] [Related]
35. Recognizing apathy in Alzheimer's disease. Lerner AJ; Strauss M; Sami SA Geriatrics; 2007 Nov; 62(11):14-7. PubMed ID: 17999565 [TBL] [Abstract][Full Text] [Related]
36. Navigating patients and caregivers through the course of Alzheimer's disease. Aupperle PM J Clin Psychiatry; 2006; 67 Suppl 3():8-14; quiz 23. PubMed ID: 16649846 [TBL] [Abstract][Full Text] [Related]
37. Biochemical models for cognition enhancers. Costall B; Barnes JM; Hamon M; Müller WE; Briley M Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():85-8; discussion 89. PubMed ID: 2186420 [TBL] [Abstract][Full Text] [Related]
38. Early human trials in the assessment of cognition activators. Gamzu ER; Birkhimer LJ; Hoover T; Gracon ST Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():44-8. PubMed ID: 2186411 [TBL] [Abstract][Full Text] [Related]
39. The development of behavioral tests to assess the effects of cognitive enhancers. Olton DS; Wenk L Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():65-9. PubMed ID: 2186416 [TBL] [Abstract][Full Text] [Related]